Aterian Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? Aterian Inc trades at $0.48 (market cap $5.32M), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M). The key difference: Ginkgo Bioworks Holdings Inc is far larger — about 95.1× Aterian Inc's market cap. Which is the better fit depends on your goals.
| ATER | DNA | |
|---|---|---|
Market Cap | $5.32M | $505.73M |
Sector | Consumer Cyclical | Health |
52-Week High | $1.39 | $16.14 |
52-Week Low | $0.36 | $5.48 |
Enterprise Value | $5.90M | $607.68M |
Trailing returns across standard periods
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →